|
|
Reference
|
|
   
|
Ahmadmehrabi, S., Tang, W.H. (2017) Gut microbiome and its role in cardiovascular diseases. Curr Opin Cardiol, 32(6), 761-766
|
|
|
Andraws, R., Berger, J.S., Brown, D.L. (2005) Effects of antibiotic therapy on outcomes of patients with coronary artery disease: A meta-analysis of randomized controlled trials. JAMA, 293, 2641-2647
|
|
|
Antal, I., Jelić, M., Sila, S., Kolaček, S., Tambić-Andrašević, A. (2019) Ljudska mikrobiota i mikrobiom. Acta medica Croatica, 73(1), 3-11, https://hrcak.srce.hr
|
|
|
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., Deroos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J., Rudensky, A.Y. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 504(7480), 451-455
|
|
|
Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F., Gordon, J.I. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences, 101(44), 15718-15723
|
|
|
Bäckhed, F., Manchester, J.K., Semenkovich, C.F., Gordon, J.I. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences, 104(3), 979-984
|
|
|
Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761-1772
|
|
|
Chambers, E.S., Byrne, C.S., Morrison, D.J., Murphy, K.G., Preston, T., Tedford, C., Garcia-Perez, I., Fountana, S., Serrano-Contreras, J.I., Holmes, E., Reynolds, C.J., Roberts, J.F., Boyton, R.J. (2019) Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: A randomised cross-o. Gut, 68(8), 1430-1438
|
|
|
Chambers, E.S., Preston, T., Frost, G., Morrison, D.J. (2018) Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health. Current Nutrition Reports, 7(4), 198-206
|
|
|
Colman, R.J., Rubin, D.T. (2014) Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis. Journal of Crohn's and Colitis, 8(12), 1569-1581
|
|
|
Conraads, V.M., Jorens, P.G., de Clerck, L.S., van Saene, H.K., Ieven, M.M., Bosmans, J.M., Schuerwegh, A., Bridts, C.H., Wuyts, F., Stevens, W.J., Anker, S.D., Rauchhaus, M., Vrints, C.J. (2004) Selective intestinal decontamination in advanced chronic heart failure: A pilot trial. European Journal of Heart Failure, 6(4), 483-491
|
|
|
Costanza, A.C., Moscavitch, S.D., Faria, N.H.C.C., Mesquita, E.T. (2015) Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial. International Journal of Cardiology, 179, 348-350
|
|
|
David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505(7484), 559-563
|
|
|
de Filippis, F., Pellegrini, N., Vannini, L., Jeffery, I.B., Storia, L.A., Laghi, L., et al. (2016) High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut, 65(11), 1812-1821
|
|
|
de la Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C., Raybould, H.E. (2010) Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology, 299(2), G440-G448
|
|
|
Duncan, S.H., Barcenilla, A., Stewart, C.S., Pryde, S.E., Flint, H.J. (2002) Acetate utilization and butyryl coenzyme A (CoA): Acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Applied and Environmental Microbiology, 68(10), 5186-5190
|
|
|
Fox, M.A., Peterson, S., Fabri, B.M., van Saene, H.K.F., Williets, T. (1991) Selective decontamination of the digestive tract in cardiac surgical patients. Critical Care Medicine, 19(12), 1486-1490
|
|
|
Gan, X.T., Ettinger, G., Huang, C.X., Burton, J.P., Haist, J.V., Rajapurohitam, V., et al. (2014) Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail, 7(3), 491-499
|
|
|
Gan, X.T., Ettinger, G., Huang, C.X., Burton, J.P., Haist, J.V., Rajapurohitam, V., Sidaway, J.E., Martin, G., Gloor, G.B., Swann, J.R., Reid, G., Karmazyn, M. (2014) Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circulation: Heart Failure, 7(3), 491-499
|
|
|
Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J., Scott, K., Stanton, C., Swanson, K.S., Cani, P.D., Verbeke, K., Reid, G. (2017) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology, 14(8), 491-502
|
|
|
Gomez-Arango, L.F., Barrett, H.L., McIntyre, D.H., Callaway, L.K., Morrison, M., Dekker, N.M. (2016) Increased systolic and diastolic blood pressure is associated with altered gut microbiota composition and butyrate production in early pregnancy. Hypertension, 68(4), 974-981
|
|
|
Harris, K., Kassis, A., Major, G., Chou, C.J. (2012) Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?. Journal of Obesity, 2012, 879151
|
|
|
He, Z., Wang, J., Chen, Y., Cong, X., Li, N., Ding, R., Hultgårdh-Nilsson, A., Liang, C. (2019) Potential risk associated with direct modulation of the gut flora in patients with heart failure. ESC Heart Failure, 6(3), 555-556
|
|
1
|
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C., Sanders, M.E. (2014) The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506-514
|
|
|
Honour, J. (1982) The possible involvement of intestinal bacteria in steroidal hypertension. Endocrinology, 110(1), 285-287
|
|
|
Jia, Q., Li, H., Zhou, H., Zhang, X., Zhang, A., Xie, Y., et al. (2019) Microbiota and irritable bowel syndrome: A critical inventory. Cardiovasc Ther, 2019, 5164298
|
|
|
Jin, M., Qian, Z., Yin, J., Xu, W., Zhou, X. (2019) The role of intestinal microbiota in cardiovascular disease. Journal of Cellular and Molecular Medicine, 23(4), 2343-2350
|
|
|
Johnson, L.P., Walton, G.E., Psichas, A., Frost, G.S., Gibson, G.R., Barraclough, T.G. (2015) Prebiotics modulate the effects of antibiotics on gut microbial diversity and functioning in vitro. Nutrients, 7(6), 4480-4497
|
|
|
Kamo, T., Akazawa, H., Suda, W., Saga-Kamo, A., Shimizu, Y., Yagi, H., Liu, Q., Nomura, S., Naito, A.T., Takeda, N., Harada, M., Toko, H., Kumagai, H., Ikeda, Y., Takimoto, E., Suzuki, J. (2017) Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS One, 12(3), e0174099
|
|
|
Karbach, S.H., Schönfelder, T., Brandão, I., Wilms, E., Hörmann, N., Jäckel, S., Schüler, R., Finger, S., Knorr, M., Lagrange, J., Brandt, M., Waisman, A., Kossmann, S., Schäfer, K., Münzel, T., Reinhardt, C. (2016) Gut microbiota promotes angiotensin II-induced arterial hy pertension and vascular dysfunction. Journal of the American Heart Association, 5(9), e003698
|
|
|
Karlsson, F.H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., et al. (2012) Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun, 3(1), 1245
|
|
|
Kitai, T., Kirsop, J., Tang, W.H. (2016) Exploring the microbiome in heart failure. Curr Heart Fail Rep, 13(2),103-109
|
|
|
Knoop, K.A., Mcdonald, K.G., Kulkarni, D.H., Newberry, R.D. (2016) Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut, 65(7), 1100-1109
|
|
|
Koh, A., de Vadder, F., Kovatcheva-Datchary, P., Bäckhed, F. (2016) From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332-1345
|
|
|
Kummen, M., Mayerhofer, C.C.K., Vestad, B., Broch, K., Awoyemi, A., Storm-Larsen, C., Ueland, T., Yndestad, A., Hov, J.R., Trøseid, M. (2018) Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts. Journal of the American College of Cardiology, 71(10), 1184-1186
|
|
|
Lam, V., Su, J., Koprowski, S., Hsu, A., Tweddell, J.S., Rafiee, P., Gross, G.J., Salzman, N.H., Baker, J.E. (2012) Intestinal microbiota determine severity of myocardial infarction in rats. FASEB Journal, 26(4), 1727-1735
|
|
|
Lam, V., Su, J., Hsu, A., Gross, G.J., Salzman, N.H., Baker, J.E. (2016) Intestinal microbial metabolites are linked to severity of myocardial infarction in rats. PLoS One, 11(8), e0160840
|
|
|
Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I. (2005) Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences, 102(31), 11070-11075
|
|
|
Lin, P.P., Hsieh, Y.M., Kuo, W.W., Lin, Y.M., Yeh, Y.L., Lin, C.C., et al. (2013) Probiotic-fermented purple sweet potato yogurt activates compensatory IGFIR/PI3K/Akt survival pathways and attenuates cardiac apoptosis in the hearts of spontaneously hypertensive rats. Int J Mol Med, 32(6), 1319-1328
|
|
|
Lloyd-Price, J., Abu-Ali, G., Huttenhower, C. (2016) The healthy human microbiome. Genome Medicine, 8(1), 51-51
|
|
|
Lopez-Garcia, E., Rodriguez-Artalejo, F., Li, T.Y., Fung, T.T., Li, S., Willett, W.C., et al. (2014) The Mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease. Am J Clin Nutr, 99(1), 172-180
|
|
|
Louis, P., Flint, H.J. (2017) Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology, 19(1), 29-41
|
|
|
Luedde, M., Winkler, T., Heinsen, F.A., Rühlemann, M.C., Spehlmann, M.E., Bajrovic, A., Lieb, W., Franke, A., Ott, S.J., Frey, N. (2017) Heart failure is associated with depletion of core intestinal microbiota. ESC Heart Failure, 4(3), 282-290
|
|
|
Ma, J., Li, H. (2018) The role of gut microbiota in atherosclerosis and hypertension. Front Pharmacol, 9, 1082
|
|
|
Marques, F.Z., Nelson, E., Chu, P.Y., Horlock, D., Fiedler, A., Ziemann, M., Tan, J.K., Kuruppu, S., Rajapakse, N.W., El-Osta, A., Mackay, C.R., Kaye, D.M. (2017) High-fiber diet and acetate supplementation change the gut microbi-ota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation, 135(10), 964-977
|
|
|
Mayerhofer, C.C.K., Awoyemi, A., Hov, J.R., Trøseid, M., Broch, K. (2019) Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure. ESC Heart Failure, 6(3), 557-558
|
|
|
Miyamoto, J., Kasubuchi, M., Nakajima, A., Irie, J., Itoh, H., Kimura, I. (2016) The role of short-chain fatty acid on blood pressure regulation. Current Opinion in Nephrology and Hypertension, 25(5), 379-383
|
|
|
Nallu, A., Sharma, S., Ramezani, A., Muralidharan, J., Raj, D. (2017) Gut microbiome in chronic kidney disease: Challenges and opportunities. Transl Res, 179, 24-37
|
|
|
Natarajan, N., Hori, D., Flavahan, S., Steppan, J., Flavahan, N.A., Berkowitz, D.E., Pluznick, J.L. (2016) Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiological Genomics, 48(11), 826-834
|
|
|
Niebauer, J., Volk, H.D., Kemp, M., Dominguez, M., Schumann, R.R., Rauchhaus, M., et al. (1999) Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet, 353(9167), 1838-1842
|
|
|
Ott, S.J., El, M.N.E., Musfeldt, M., Hellmig, S., Freitag, S., Rehman, A., et al. (2006) Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation, 113(7), 929-937
|
|
|
Packer, C.S., Rice, A.E., Johnson, T.C. (2014) Oxidized low density lipoprotein (OX-LDL) induced arterial muscle contraction signaling mechanisms. Open Hypertension Journal, 6(1), 20-26
|
|
|
Pasini, E., Aquilani, R., Testa, C., Baiardi, P., Angioletti, S., Boschi, F., Verri, M., Dioguardi, F. (2016) Pathogenic gut flora in patients with chronic heart failure. JACC: Heart Failure, 4(3), 220-227
|
|
|
Patel, R., Dupont, H.L. (2015) New approaches for bacteriotherapy: Prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis, 60, 108-121
|
|
|
Patterson, E., Cryan, J.F., Fitzgerald, G.F., Ross, P.R., Dinan, T.G., Stanton, C. (2014) Gut microbiota, the pharmabiotics they produce and host health. Proceedings of the Nutrition Society, 73(4), 477-489
|
|
|
Petrof, E.O., Gloor, G.B., Vanner, S.J., Weese, S.J., Carter, D., Daigneault, M.C., Brown, E.M., Schroeter, K., Allen-Vercoe, E. (2013) Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome, 1(1), 3
|
|
|
Pluznick, J.L., Protzko, R.J., Gevorgyan, H., Peterlin, Z., Sipos, A., Han, J., Brunet, I., Wan, L., Rey, F., Wang, T., Firestein, S.J., Yanagisawa, M., Gordon, J.I., Eichmann, A., Peti-Peterdi, J. (2013) Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proceedings of the National Academy of Sciences, 110(11), 4410-4415
|
|
|
Qi, Y., Aranda, J.M., Rodriguez, V., Raizada, M.K., Pepine, C.J. (2015) Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension: A case report. Int J Cardiol, 201, 157-158
|
|
|
Rey, F.E., Faith, J.J., Bain, J., Muehlbauer, M.J., Stevens, R.D., Newgard, C.B., Gordon, J.I. (2010) Dissecting the in vivo metabolic potential of two human gut acetogens. Journal of Biological Chemistry, 285(29), 22082-22090
|
|
|
Rifai, L., Pisano, C., Hayden, J., Sulo, S., Silver, M.A. (2015) Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure. Baylor University Medical Center Proceedings, 28(2), 151-156
|
|
|
Salehi-Abargouei, A., Maghsoudi, Z., Shirani, F., Azadbakht, L. (2013) Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases-incidence: a systematic review and metaanalysis on observational prospective studies. Nutrition, 29(4), 611-618
|
|
|
Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., Hammer, R.E., Williams, S.C., Crowley, J., Yanagisawa, M., Gordon, J.I. (2008) Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences, 105(43), 16767-16772
|
|
|
Sekirov, I., Russell, S.L., Antunes, L.C., Finlay, B.B. (2010) Gut microbiota in health and disease. Physiol Rev, 90(3), 859-904
|
|
|
Seung, K.J., Kang, S., Lee, H., Yoon, C., Suh, J., Cho, Y. (2020) Metagenomic analysis of microbiota in patients with st-segment elevation myocardial infarction 2. Oral, gut, and thrombus microbiome in st-segment elevation myocardial infarction 112. JACC, 75(11)
|
|
|
Skok, P., Skok, K. (2020) Prebavna cev in srčno-žilne bolezni - ali imajo kaj skupnega?. Zdrav Vestn, 89(9-10), 528-538
|
|
|
Tamburini, S., Shen, N., Wu, H.C., Clemente, J.C. (2016) The microbiome in early life: Implications for health outcomes. Nat Med, 22(7), 713-722
|
|
|
Tan, J.K., McKenzie, C., Mariño, E., Macia, L., Mackay, C.R. (2017) Metabolite-sensing G protein-coupled receptors facilitators of diet-related immune regulation. Annual Review of Immunology, 35(1), 371-402
|
|
|
Tang, T.W.H., Chen, H.C., Chen, C.C., Yen, C.Y.T., Lin, C.J., Prajnamitra, R.P., Chen, L.C., Ruan, S., Lin, J.J., Lin, P.J., Lu, H., Kuo, C., Chang, C.M., Hall, A.D. (2019) Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation, 139(5), 647-659
|
|
|
Tang, W.H., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., et al. (2013) Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med, 368(17), 1575-1584
|
|
|
Tang, W.H., Kitai, T., Hazen, S.L. (2017) Gut microbiota in cardiovascular health and disease. Circ Res, 120(7), 1183-1196
|
|
|
Tang, W., Wang, Z., Fan, Y., Levison, B., Hazen, J.E., Donahue, L.M., et al. (2014) Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-n-oxide in patients with heart failure: Refining the gut hypothesis. J Am Coll Cardiol, 64(18), 1908-1914
|
|
|
Tiihonen, K., Tynkkynen, S., Ouwehand, A., Ahlroos, T., Rautonen, N. (2008) The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology. British Journal of Nutrition, 100(1), 130-137
|
|
|
Townsend, M.K., Aschard, H., de Vivo, I., Michels, K.B., Kraft, P.B. (2016) Genomics, telomere length, epigenetics, and metabolomics in the nurses' health studies. American Journal of Public Health, 106(9), 1663-1668
|
|
|
Trøseid, M., et al. (2020) The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions review. 52, 102649-102649
|
|
|
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444(7122), 1027-1031
|
|
|
Vinod, N. (2019) The novel dimensions of cardio-metabolic health: Gut microbiota, dysbiosis and its fallouts. Curre Res Diabetes & Obes J, 11(1), 555805
|
|
|
Vrieze, A., van Nood, E., Holleman, F., Salojärvi, J., Kootte, R.S., et al. (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology, 143(4), 913-916
|
|
|
Wang, Z., Roberts, A.B., Buffa, J.A., Levison, B.S., Zhu, W., Org, E., et al. (2015) Non-lethal inhibition of gut microbial trimethylamine production for the treatment of therosclerosis. Cell, 163, 1585-1595
|
|
|
Winkel, P., Hilden, J., Hansen, J.F., Kastrup, J., Kolmos, H.J., Kjoller, E., et al. (2015) Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the claricor randomised, blinded clinical trial. Int J Cardiol, 182, 459-465
|
|
|
Yamashiro, K., Tanaka, R., Urabe, T., Ueno, Y., Yamashiro, Y., Nomoto, K., Takahashi, T., Tsuji, H., Asahara, T., Hattori, N. (2017) Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One, 12(2), e0171521-e0171521
|
|
|
Yang, T., Santisteban, M.M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J.M., Zadeh, M., Gong, M., Qi, Y., Zubcevic, J., Sahay, B., Pepine, C.J., Raizada, M.K., Mohamadzadeh, M. (2015) Gut dysbiosis is linked to hypertension. Hypertension, 65(6), 1331-1340
|
|
|
Yelin, I., Flett, K.B., Merakou, C., Mehrotra, P., Stam, J., Snesrud, E., et al. (2019) Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med, 25, 1728-1732
|
|
|
Zhou, X., Li, J., Guo, J., Geng, B., Ji, W., Zhao, Q., et al. (2018) Gutdependent microbial translocation induces inflammation and cardiovascular events after STelevation myocardial infarction. Microbiome, 6(1), 66
|
|
|
|
|